[Nafditrofuryl and carotid spasms].
D002340:Carotid Artery Diseases / Q000000981:diagnostic imaging / Q000188:drug therapy*; D002533:Cerebral Angiography; D002648:Child; D003937:Diagnosis, Differential; D005021:Ethylamines / Q000627:therapeutic use; D005663:Furans; D006801:Humans; D007269:Injections, Intra-Arterial; D002546:Ischemic Attack, Transient / Q000000981:diagnostic imaging / Q000188:drug therapy*; D008297:Male; D008722:Methods; D009281:Naphthalenes / Q000627:therapeutic use*; D010208:Papaverine / Q000627:therapeutic use; D011422:Propionates / Q000627:therapeutic use; D013035:Spasm / Q000000981:diagnostic imaging / Q000188:drug therapy*; D013565:Sympatholytics / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use*
D005021:Ethylamines; D005663:Furans; D009281:Naphthalenes; D011422:Propionates; D013565:Sympatholytics; D014665:Vasodilator Agents; D010208:Papaverine
Nafditrofuryl et spasmes carotidiens.